Cullinan Oncology LLC

NASDAQ CGEM

Data sourced from iex and EODHD
Download Data

Cullinan Oncology LLC Income Statement 2012 - 2024

This table shows the Income Statement for Cullinan Oncology LLC going from 2012 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Revenue
M 0 0 0 0 0 0 -38 -38 -38 -19 19 19 19 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - -
Cost of Revenue
M 0 0 0 - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - -
Gross Profit
M 0 0 0 - - - -38 -38 -38 -19 19 19 19 - - 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - -
Operating Expenses
M 171 191 178 - - - -4 -4 -4 14 18 18 18 - - 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 44 42 43 42 43 40 42 38 32 29 28 24 21 17 6 4 3 1 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 0 0 0
Research and Development (R&D) Expenses
M 127 148 135 120 120 92 92 85 70 58 54 51 51 43 30 20 8 4 - - - - - - - - - - - - - - - - - - - -
Other Operating Expenses
M 0 0 0 - - - -38 -38 -38 -38 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - -
Costs and Expenses
M 170 190 177 - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - -
Operating Income
M -171 -191 -178 -163 115 145 143 154 -102 -68 -63 -56 -53 -60 -36 -25 -11 -5 0 0 0 0 0 0 - - - - - - - - - - - - - -
Interest Expense
M - -5 -8 10 11 6 3 1 1 0 0 0 1 1 1 1 0 - - - - - - - - - - - - - - - - - - - - -
Non-operating Income/Expense
M 11 10 8 11 11 7 3 1 0 0 0 0 0 1 1 1 1 0 0 0 0 0 0 0 - - - - - - - - - - - - - -
EBT
M -148 -169 -158 -147 126 151 146 155 -101 -67 -62 -55 -53 -59 -35 -24 -10 -5 0 0 0 0 0 0 - - - - - - - - - - - - - -
Income Tax Provision
M -25 -25 -13 -10 62 42 44 46 -21 0 6 6 1 0 -7 -6 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - -
Income after Tax
M -123 -144 -146 -137 64 109 102 110 -80 -67 -69 -61 -54 -59 -28 -18 -10 -5 0 0 0 0 0 0 - - - - - - - - - - - - - -
Non-Controlling Interest
M 0 0 -1 -1 -2 -2 -2 -2 -2 1 0 -2 -8 -9 -9 -7 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - -
Net Income
M -32 -90 -117 -142 65 111 105 113 -78 -66 -61 -54 -45 -50 -22 -12 -5 0 0 0 0 0 0 0 - - - - - - - - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 42,122,750.00 41,540,500.00 42,279,750.00 42,999,000.00 44,606,250.00 45,543,664.25 45,016,763.50 44,473,763.50 43,702,263.50 43,088,683.25 42,672,168.00 41,270,227.25 35,286,844.00 29,632,876.75 23,978,909.50 19,361,467.00 19,361,467.00 19,361,467.00 - - - - - - - - - - - - - - - - - - - -
EBITDA
M -170 -190 -177 -163 -439 -409 -411 -399 -102 -68 -63 -56 -53 -60 -36 -25 -10 -5 - - - - - - - - - - - - - - - - - - - -
Depreciation and Amortization
M 0 0 0 0 -553 -553 -554 -554 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - -
EBIT
M -171 -190 -177 -163 114 145 143 154 -102 -68 -63 -56 -53 -60 -36 -25 -11 -5 0 0 0 0 0 0 - - - - - - - - - - - - - -
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% 16.69 16.64 9.35 8.18 10.86 25.85 24.09 23.19 17.80 27.83 22.07 23.88 32.31 8.12 14.90 11.68 1.78 0.86 0.00 0.00 0.00 0.00 0.00 0.00 - - - - - - - - - - - - - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - -
Gross Profit Margin
% - - - - - - 100.00 100.00 100.00 100.00 100.00 100.00 100.00 - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Income Margin
% - - - - - - 90.75 90.75 90.75 48.99 7.24 7.24 7.24 - - - - - - - - - - - - - - - - - - - - - - - - -
Net Income Margin
% - - - - - - 85.91 85.91 85.91 42.77 -0.37 -0.37 -0.37 - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDA Ratio
% - - - - - - 90.75 90.75 90.75 48.99 7.24 7.24 7.24 - - - - - - - - - - - - - - - - - - - - - - - - -
EBIT Ratio
% - - - - - - 90.78 90.78 90.78 48.97 7.16 7.16 7.16 - - - - - - - - - - - - - - - - - - - - - - - - -
EBT Ratio
% - - - - - - 90.37 90.37 90.37 48.93 7.49 7.49 7.49 - - - - - - - - - - - - - - - - - - - - - - - - -

StockViz Staff

September 16, 2024

Any question? Send us an email